In this clinical trials the sponsor want to assess a self-controlled-energo-neuroadaptative-regulation in patient with urge incontinence

In this clinical trials the sponsor want to assess a self-controlled-energo-neuroadaptative-regulation in patient with urge incontinence and mixted incontinence

Inclusion Criteria:

• Urge incontinence or mixed incontinence without urethral hypermobility
• Over 3 months of disease evolves.

Exclusion Criteria:

• Severe physical limitations that might interfere with applying the treatment.
• Severe mental disorders that need pharmacology treatments that may influence in neuronal activity
• Oncological processes in the lower abdomen that had required radical surgery.
• Neurogenic bladder.
• Blockage of the bladder
• Vaginal infection
• Bladder infection or disorder of kidney function
• Have received, in the last year, botulinum toxin in bladder or pelvic organs.
• Have received pharmacological treatment for urge incontinence in the last month (before entry date in the trial)
• Be receiving pharmacological treatment for urge incontinence.
• Stress incontinence due to urethral hypermobility which was treatable with surgery.
• Pregnant women
• Patients with pacemarker